Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics

The PI3K/AKT/mTOR pathway is central in regulating key cellular processes such as proliferation, survival, metabolism, and angiogenesis. Dysregulation of this pathway, particularly in the AKT2 isoform, is commonly observed in cancers such as breast, ovarian, and pancreatic cancers, leading to enhanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Jibon Kumar Paul, Mahir Azmal, Md Naimul Haque Shohan, Mohua Mrinmoy, ANM Shah Newaz Been Haque, Omar Faruk Talukder, Ajit Ghosh
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025002774
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573081541935104
author Jibon Kumar Paul
Mahir Azmal
Md Naimul Haque Shohan
Mohua Mrinmoy
ANM Shah Newaz Been Haque
Omar Faruk Talukder
Ajit Ghosh
author_facet Jibon Kumar Paul
Mahir Azmal
Md Naimul Haque Shohan
Mohua Mrinmoy
ANM Shah Newaz Been Haque
Omar Faruk Talukder
Ajit Ghosh
author_sort Jibon Kumar Paul
collection DOAJ
description The PI3K/AKT/mTOR pathway is central in regulating key cellular processes such as proliferation, survival, metabolism, and angiogenesis. Dysregulation of this pathway, particularly in the AKT2 isoform, is commonly observed in cancers such as breast, ovarian, and pancreatic cancers, leading to enhanced tumor progression, metastasis, and therapeutic resistance. Therefore, targeting AKT2 for inhibition is a promising strategy for cancer therapy. This study utilized molecular docking and dynamics simulations to identify natural phytochemicals that inhibit AKT2. Molecular docking results revealed that millettone (CID 442810) exhibited the highest binding affinity to AKT2, with a docking score of −9.5 kcal/mol, followed by uzarigenin (CID 92760), dihydrobiochanin A (CID 439784), and abyssinone I (CID 442152) with docking scores of −9.0 kcal/mol, −8.9 kcal/mol, and −8.7 kcal/mol respectively, outperforming the control inhibitor, ipatasertib (CID 24788740) docking score of −7.56 kcal/mol. Molecular dynamics simulations indicated that millettone, uzarigenin, and dihydrobiochanin A demonstrated strong binding affinities and stable interactions with AKT2, suggesting their potential as therapeutic agents for cancers that involve AKT2 hyperactivation. Notably, uzarigenin's superior stability, as evidenced by its lower root mean square deviation (RMSD), which measures structural stability, and solvent-accessible surface area (SASA), which indicates molecular compactness, highlights its promise as a potent inhibitor of AKT2. Future in vitro and in vivo studies will be crucial to confirm the efficacy of these inhibitors in reducing tumor progression and their potential applications. Given that AKT2 also plays a role in neuronal survival and plasticity, these compounds may have potential applications in neurodegenerative diseases such as Alzheimer's, warranting further investigation into their dual therapeutic relevance.
format Article
id doaj-art-66293552a7af4b53a855d7234f3af838
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-66293552a7af4b53a855d7234f3af8382025-02-02T05:28:30ZengElsevierHeliyon2405-84402025-01-01112e41897Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeuticsJibon Kumar Paul0Mahir Azmal1Md Naimul Haque Shohan2Mohua Mrinmoy3ANM Shah Newaz Been Haque4Omar Faruk Talukder5Ajit Ghosh6Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshCorresponding author.; Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, BangladeshThe PI3K/AKT/mTOR pathway is central in regulating key cellular processes such as proliferation, survival, metabolism, and angiogenesis. Dysregulation of this pathway, particularly in the AKT2 isoform, is commonly observed in cancers such as breast, ovarian, and pancreatic cancers, leading to enhanced tumor progression, metastasis, and therapeutic resistance. Therefore, targeting AKT2 for inhibition is a promising strategy for cancer therapy. This study utilized molecular docking and dynamics simulations to identify natural phytochemicals that inhibit AKT2. Molecular docking results revealed that millettone (CID 442810) exhibited the highest binding affinity to AKT2, with a docking score of −9.5 kcal/mol, followed by uzarigenin (CID 92760), dihydrobiochanin A (CID 439784), and abyssinone I (CID 442152) with docking scores of −9.0 kcal/mol, −8.9 kcal/mol, and −8.7 kcal/mol respectively, outperforming the control inhibitor, ipatasertib (CID 24788740) docking score of −7.56 kcal/mol. Molecular dynamics simulations indicated that millettone, uzarigenin, and dihydrobiochanin A demonstrated strong binding affinities and stable interactions with AKT2, suggesting their potential as therapeutic agents for cancers that involve AKT2 hyperactivation. Notably, uzarigenin's superior stability, as evidenced by its lower root mean square deviation (RMSD), which measures structural stability, and solvent-accessible surface area (SASA), which indicates molecular compactness, highlights its promise as a potent inhibitor of AKT2. Future in vitro and in vivo studies will be crucial to confirm the efficacy of these inhibitors in reducing tumor progression and their potential applications. Given that AKT2 also plays a role in neuronal survival and plasticity, these compounds may have potential applications in neurodegenerative diseases such as Alzheimer's, warranting further investigation into their dual therapeutic relevance.http://www.sciencedirect.com/science/article/pii/S2405844025002774ATK2Molecular dockingMolecular dynamics simulationUzarigeninOncogenesis
spellingShingle Jibon Kumar Paul
Mahir Azmal
Md Naimul Haque Shohan
Mohua Mrinmoy
ANM Shah Newaz Been Haque
Omar Faruk Talukder
Ajit Ghosh
Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
Heliyon
ATK2
Molecular docking
Molecular dynamics simulation
Uzarigenin
Oncogenesis
title Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
title_full Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
title_fullStr Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
title_full_unstemmed Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
title_short Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
title_sort identification of natural phytochemicals as akt2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
topic ATK2
Molecular docking
Molecular dynamics simulation
Uzarigenin
Oncogenesis
url http://www.sciencedirect.com/science/article/pii/S2405844025002774
work_keys_str_mv AT jibonkumarpaul identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT mahirazmal identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT mdnaimulhaqueshohan identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT mohuamrinmoy identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT anmshahnewazbeenhaque identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT omarfaruktalukder identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics
AT ajitghosh identificationofnaturalphytochemicalsasakt2inhibitorsusingmoleculardockinganddynamicssimulationsaspotentialcancertherapeutics